diethylnitrosamine has been researched along with glycoprotein e2, hepatitis c virus in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blackard, JT; Choe, WH; Chung, RT; Fowler, N; Hiasa, Y; Kamegaya, Y; Lin, W; Schmidt, EV; Zukerberg, L | 1 |
1 other study(ies) available for diethylnitrosamine and glycoprotein e2, hepatitis c virus
| Article | Year |
|---|---|
Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis.
Topics: Animals; Apoptosis; Cell Proliferation; Diethylnitrosamine; Disease Models, Animal; fas Receptor; Hepacivirus; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Viral Envelope Proteins | 2005 |